Healthcare / Health Information ServicesNasdaqGS
$25.59
+0.62 (+2.48%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 21% · confianza 25%
FCF escenarios
weak_data · normalized FCF $31.2M · quality 83.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$748M
P/E
38.2x
↑EV/EBITDA
11.8x
↓ROE
5.2%
↑Gross Margin
64.7%
↑Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+11.0%
FCF CAGR
+7.5%
FCF margin
10.2%
FCF / Net income
1.70x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $304.1M · net income $18.3M · FCF $31.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $304.1M | $304.1M | $291.6M | $279.1M | $266.8M | $256.7M | $244.8M | $254.1M | $231.6M | $214.9M | $192.1M | $209.0M | $170.7M | $132.3M | $103.7M | $82.1M | $65.8M | $57.4M |
| Net Income | $18.3M | $18.3M | $20.0M | $15.2M | $12.1M | $5.8M | $14.1M | $15.8M | $32.2M | $10.0M | $3.8M | $8.6M | $10.4M | $8.4M | $7.6M | $6.9M | $4.2M | $14.0M |
| EBITDA | $63.7M | $63.7M | $62.5M | $57.1M | $50.4M | $44.9M | $46.0M | $42.6M | $39.7M | $33.5M | $27.5M | $30.6M | $27.3M | $22.5M | $20.1M | $16.8M | $11.9M | $10.3M |
| EPS | 0.61 | 0.61 | 0.66 | 0.50 | 0.39 | 0.18 | 0.44 | 0.49 | 1.00 | 0.31 | 0.12 | 0.28 | 0.37 | 0.30 | 0.28 | 0.29 | 0.18 | 0.64 |
| Gross Margin | 64.7% | 64.7% | 66.4% | 65.9% | 65.8% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 6.7% | 6.7% | 7.3% | 5.7% | 4.7% | 3.1% | 6.5% | 5.8% | 6.7% | 4.4% | 3.7% | 6.5% | 9.6% | 11.1% | 13.0% | 13.8% | 10.7% | 8.9% |
| Net Margin | 6.0% | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | 5.8% | 6.2% | 13.9% | 4.7% | 2.0% | 4.1% | 6.1% | 6.4% | 7.4% | 8.5% | 6.3% | 24.3% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.04 | 0.04 | 0.05 | 0.06 | 0.07 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | 0.97 | 0.97 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $31.2M | $31.2M | $29.5M | $36.0M | $26.1M | $39.0M | $33.9M | $43.7M | $36.1M | $41.2M | $19.4M | — | — | $21.8M | $18.2M | $15.6M | $13.5M | $9.8M |
| Returns | ||||||||||||||||||
| ROE | 5.2% | 5.2% | 5.6% | 4.5% | 3.6% | 1.7% | 4.2% | 4.7% | 10.1% | 3.3% | 1.3% | 3.1% | 6.2% | 5.6% | 5.8% | 5.7% | 7.3% | 27.0% |
| Valuation | ||||||||||||||||||
| P/E | 38.19 | 38.19 | 48.55 | 52.32 | 61.72 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 11.77 | 11.77 | 14.98 | 13.70 | 14.22 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 2.18 | 2.18 | 2.72 | 2.35 | 2.21 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 4.3% | 4.3% | 4.5% | 4.6% | — | 4.9% | -3.7% | 9.7% | 7.8% | 11.9% | -8.1% | 22.4% | 29.0% | 27.5% | 26.4% | 24.8% | 14.6% | — |
| EPS Growth | -7.6% | -7.6% | 32.0% | 28.2% | — | -59.1% | -10.2% | -51.0% | 222.6% | 158.3% | -57.1% | -24.3% | 23.3% | 7.1% | -3.4% | 61.1% | -71.9% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
55.0%
EPS terminal req.
$2.27
Spread vs growth
-62.6%
5Y implied EPS CAGR
35.1%
EPS terminal req.
$2.75
Spread vs growth
-42.7%
10Y implied EPS CAGR
21.9%
EPS terminal req.
$4.42
Spread vs growth
-29.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-8.2%
Start / end P/E
42.5x → 42.0x
EPS bridge
0.66 → 0.61
Residual
+0.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.